Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for moderate sedation during shoulder reduction in the emergency department
IRCT2013011312115N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of remifentanil in anterior shoulder dislocation, sponsored by Mashhad University of Medical Sciences. Started Feb 2013; status: completed.
02
Drugs
remifentanil
03
Conditions
anterior shoulder dislocation
Beyond the preview
Go deeper on IRCT2013011312115N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013011312115N1.